Gorm Roager Madsen

Gorm Roager Madsen

Auto-generated profile, based on publicly available information

Gorm Roager Madsen

Gastrounit, Medical Section Copenhagen University Hospital‐Amager and Hvidovre Hvidovre Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
GMGorm Roager Madsen
Gorm Roager Madsen
KBKristina Bertl
Kristina Bertl
NPNikolaos Pandis
Nikolaos Pandis
ASAndreas Stavropoulos
Andreas Stavropoulos
JBJohan Burisch
Johan Burisch
Background: Inflammatory bowel disease (IBD) and periodontitis are chronic, progressive, inflammatory diseases with similarly complex pathogeneses that involve an interplay between dysbiotic microbiota and dysregulated immune-inflammatory responses. However, whether the presence of periodontitis is associated with IBD activity and/or its severity remains unknown.Methods: An online, questionnaire-based study was answered by 1093 patients with IBD, comprising 527 patients with Crohn’s disease and 566 patients with ulcerative colitis. The survey included questions on social demographics; oral health, including the Periodontal Screening Score (PESS); and IBD-related characteristics, including validated disease indices.Results: Irrespective of disease subtype, patients with a reduced number of teeth and those with self-reported severe periodontitis scored significantly higher on the IBD disability index (number of teeth: coefficient, 4.93 [95% confidence interval {CI}, 1.21–8.66; P = .010]; periodontitis: coefficient, 3.54 [95% CI, 0.27–6.80; P = .034]) and reported increased disease activity in the preceding 12 months (number of teeth: odds ratio [OR], 1.91 [95% CI, 1.36–2.69; P < .001]; periodontitis: OR, 1.71 [95% CI, 1.27–2.31; P < .001]). There was also evidence of a weak association between self-reported severe periodontitis and current disease activity (OR, 1.33; 95% CI, 0.95–1.86; P = .099). However, IBD severity, as a composite parameter of a history of surgery due to IBD and/or treatment with biological therapy, was not associated with possessing a reduced number of teeth (OR, 1.18; 95% CI, 0.77–1.80; P = .451), nor with self-reported severe periodontitis (OR, 1.15; 95% CI, 0.79–1.66; P = .467).Conclusions: Periodontitis and tooth loss were significantly associated with increased IBD-related disability and more disease activity in the preceding 12 months. Our results suggest that greater attention should be paid to IBD patients’ oral health.

29 April 2022 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
GMGorm Roager Madsen
Gorm Roager Madsen
Rune WilkensRune Wilkens
Rune Wilkens
TBTrine Boysen
Trine Boysen
JBJohan Burisch
Johan Burisch
RBRobert Bryant
Robert Bryant
MTMartin Grønnebæk Tolsgaard
Martin Grønnebæk Tolsgaard
Summary: Background: Intestinal ultrasound (IUS) is a non‐invasive modality for monitoring disease activity in inflammatory bowel diseases (IBD). IUS training currently lacks well‐defined standards and international consensus on competency criteria. Aim: To achieve international consensus on what competencies should be expected from a newly certified IUS practitioner.Methods: A three‐round, iterative Delphi process was conducted among 54 IUS experts from 17 countries. Round 1 was a brainstorming phase with an open‐ended question to identify the knowledge and skills that experts believe a newly certified IUS practitioner should possess. The experts' suggestions were then organised into statements by a Steering Committee. In round 2, the experts commented upon and rated the statements, which were revised accordingly. In round 3, the experts rated the revised statements. Statements meeting the pre‐defined consensus criterion of at least 70% agreement were included in the final list of statements.Results: In total, 858 items were suggested by the experts in the first round. Based on these suggestions, 55 statements were organised into three categories: knowledge, technical skills and interpretation skills. After the second round, 53 revised statements remained. After the final round, a total of 41 statements had achieved consensus.Conclusions: We established international, expert consensus on the knowledge and skills that should be expected from newly certified IUS practitioners. These consensus statements are the first step towards mastery learning for IUS training. Educators can utilise these statements to design training programmes and evaluate the competencies of trainees before they engage in independent practice.

15 February 2024 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
PDF file
NVNora Vladimirova
Nora Vladimirova
LTLene Terslev
Lene Terslev
MAMohamed Attauabi
Mohamed Attauabi
GMGorm Madsen
Gorm Madsen
VFViktoria Fana
Viktoria Fana
MØMikkel Østergaard
Mikkel Østergaard
Objectives: Musculoskeletal [MSK] manifestations in patients with inflammatory bowel disease [IBD] are common and associated with poorer outcomes. Hence, early detection is important to optimally tailor treatment. We aimed to determine the prevalence and distribution of inflammatory lesions in peripheral joints and entheses in newly diagnosed IBD patients. Design: Patients with newly diagnosed IBD from a prospective population-based inception cohort were consecutively included. Data on MSK symptoms were collected by questionnaires and by structured rheumatological interview. Peripheral joints and entheses were assessed clinically and by ultrasound [US], using standardized definitions. Results: Of 110 included patients (mean age: 42 years, 40% male, 70 with ulcerative colitis [UC], 40 with Crohn’s disease [CD]), a history of ≥1 peripheral musculoskeletal symptom was reported by 49%. Clinical examination revealed peripheral MSK manifestations in 56 [52.3%] patients; 29 [27.1%] had ≥1 tender and/or swollen joints and 49 [45.8%] ≥1 tender entheses. Small peripheral joints were predominantly affected. US found inflammation in ≥1 joint or enthesis in 52 [49.5 %] patients; 29 [27.4 %] had US synovitis in ≥1 joint, while 36 [34%] had US enthesitis. Fibromyalgia classification criteria were fulfilled in seven [7.9%] patients. There was no difference in clinical or US findings between patients with UC and CD, nor between patients with active and inactive IBD. Conclusion: Half of the patients with newly diagnosed IBD had inflammation in their peripheral joints and/or entheses, documented by rheumatological clinical and US evaluations. This indicates a need for multidisciplinary collaboration to ensure an optimal therapeutic strategy for suppressing inflammation in all disease domains.

20 November 2024 in Journal of Crohn's and Colitis
Verified
Journal Article
Closed access
PDF file
MAMohamed Attauabi
Mohamed Attauabi
GMGorm Roager Madsen
Gorm Roager Madsen
FBFlemming Bendtsen
Flemming Bendtsen
JSJakob Benedict Seidelin
Jakob Benedict Seidelin
JBJohan Burisch
Johan Burisch
Emerging data indicate a stabilizing incidence of inflammatory bowel diseases (IBD), including ulcerative colitis (UC), Crohn’s disease (CD), and IBD unclassified (IBDU) in Western countries. We aimed to investigate the incidence of IBD, its initial clinical presentation, and patient-reported burden. Copenhagen IBD Inception Cohort is a prospective, population-based cohort of patients with newly diagnosed IBD according to the ECCO guidelines in the period between May 2021 and May 2023, within a catchment area covering 20% of the Danish population. Based on 554 patients (UC: 308, CD: 201, and IBDU: 18), the incidence rates per 100,000 person-years were: IBD: 23.4 (95% confidence interval, 21.5-25.4), UC: 14.0 (12.6-15.6), CD: 8.6 (7.4-9.8), and IBDU: 0.8 (0.5-1.3). The median diagnostic delay was significantly shorter for UC (2.5 months (interquartile range [IQR] 1-6)) than for CD (5 months (IQR 1.5-11), p<0.01). Moderate-to-severe disability was reported by 34% of CD patients and 22% of UC patients (p=0.01), severe fatigue by 30% and 26% (p=0.43), and severely impaired health-related quality of life (HRQoL) by 43% and 30% of patients, respectively (p=0.01). Hospitalization rates (UC: 20%, CD: 34%, p<0.01), and need for immunomodulators, biologics, or surgery within three months of diagnosis, were high in both UC (3%, 7%, and 37%, respectively) and CD (31%, 18%, and 10%, respectively). We found a high incidence of IBD in Copenhagen with a substantial disease burden characterized by early and high requirement for advanced therapies and high rates of fatigue, disability and impaired HRQoL at diagnosis.

11 March 2025 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
GMGorm Roager Madsen
Gorm Roager Madsen
MAMohamed Attauabi
Mohamed Attauabi
JIJohan F.K.F. Ilvemark
Johan F.K.F. Ilvemark
KTKlaus Theede
Klaus Theede
Jacob Tveiten BjerrumJacob Tveiten Bjerrum
Jacob Tveiten Bjerrum
JBJohan Burisch
Johan Burisch

20 August 2024 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
NVNora Vladimirova
Nora Vladimirova
JMJakob Møller
Jakob Møller
MAMohamed Attauabi
Mohamed Attauabi
GMGorm Madsen
Gorm Madsen
JSJakob Seidelin
Jakob Seidelin
MØMikkel Østergaard
Mikkel Østergaard
INTRODUCTION: In patients with inflammatory bowel disease (IBD), co-occurring spondyloarthritis (SpA) leads to poorer outcomes and impaired quality of life, highlighting the importance of early detection and effective treatment. This is the first study to assess the prevalence and distribution of axial symptoms and magnetic resonance imaging (MRI)-detected involvement of the spine and sacroiliac joints (SIJs) in early IBD. METHODS: Newly diagnosed patients with IBD from a prospective, population-based cohort were consecutively recruited. Rheumatological interview, clinical, ultrasound, and MRI assessment for SIJ and spine inflammatory and structural lesions were made using validated scoring methods and consensus definitions of axial SpA (axSpA). RESULTS: Of 110 patients (ulcerative colitis: 70, Crohn's disease: 40, mean age of 42 years, and 40% male), 48 (44.9%) reported back and/or buttock pain, and 10 (9.1%) had inflammatory back pain. Seventeen (16.7%) patients had MRI findings indicative of axSpA; only 10 of these patients had axial symptoms. Inflammatory MRI lesions were present in SIJs and the spine of 27 (26.5%) and 30 (30.3%) patients, respectively. The Assessment of SpondyloArthritis International Society classification criteria for axSpA were met in 11 (10%) cases. MRI findings typical of axSpA were associated with peripheral joint and entheseal inflammation detected by ultrasound (P = 0.04). No differences in clinical or imaging findings were found between patients with ulcerative colitis and Crohn's disease. DISCUSSION: One-in-6 newly diagnosed patients with IBD had MRI findings indicative of axSpA. As 40% of these patients were asymptomatic, this suggests that axSpA is underdiagnosed in early IBD. Multidisciplinary collaboration is essential to ensure early detection of axial inflammation and to enable optimal therapy preventing future structural damage and disability.